Literature DB >> 12201146

Comprehensive Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the Model 3500 I-Plant 125I brachytherapy source.

Mark J Rivard1.   

Abstract

The Model 3500 I-Plant 125I brachytherapy source, produced by Implant Sciences Corporation, is created through a novel technique which utilizes ion implantation of 124Xe into a ceramic matrix followed by neutron activation of the substrate. Clinical dosimetry parameters were calculated using MCNP. For data processing, a 0.376 cm active length was used for the geometry function. The 2-D anisotropy function, F(r, 0), exhibited less anisotropy than the Amersham Health Model 6711 source, and decreased as radial distance, r, increased. The anisotropy constant, phi an, was 0.933; dose rate constant, lambda, was 1.017 +/- 0.005 cGy/h/U; and radial dose function, g(r), for r = (0.1, 0.2, 0.5, 2, 5, 10 cm) was 0.990, 1.014, 1.030, 0.872, 0.448, and 0.114, respectively. In general, there was good agreement with experimental results recently obtained by others using thermoluminescent dosimeters.

Mesh:

Substances:

Year:  2002        PMID: 12201146     DOI: 10.1016/s0969-8043(02)00110-0

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

1.  A technical evaluation of the Nucletron FIRST system: conformance of a remote afterloading brachytherapy seed implantation system to manufacturer specifications and AAPM Task Group report recommendations.

Authors:  Mark J Rivard; Dee-Ann Radford Evans; Ian Kay
Journal:  J Appl Clin Med Phys       Date:  2005-01-12       Impact factor: 2.102

2.  Cylindrical coordinate based TG-43U1 parameters for dose calculation around elongated brachytherapy sources.

Authors:  Shahid B Awan; Sharifeh A Dini; Manzoor Hussain; David Soleimani-Meigooni; Ali S Meigooni
Journal:  J Appl Clin Med Phys       Date:  2008-04-16       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.